Literature DB >> 31482920

Recent advances in nanoparticulate biomimetic catalysts for combating bacteria and biofilms.

Xueqing Xiong1, Yanyan Huang, Changxu Lin, Xiang Yang Liu, Youhui Lin.   

Abstract

Due to the abuse of antibiotics and the tendency of bacteria to form protective biofilms, the design and development of new efficient agents that can eliminate bacteria and biofilms are still highly desired but remain a great challenge; on the other hand, natural enzymes with unique catalytic characteristics can cause an irreversible damage to the bacteria without inducing drug-resistance in the bacteria. However, the intrinsic drawbacks, such as insufficient stability and high purification cost, of enzymes significantly limit their antimicrobial applications. Therefore, significant research efforts have been devoted towards the development of quality-equivalent or even superior enzyme substitutes with low cost and high stability. In this regard, nanomaterials with extraordinary enzyme-mimetic catalytic activities (termed as nanozymes) are considered as suitable candidates. To date, nanozymes have been proved to be promising materials for combating bacteria and biofilms under mild conditions. In this review, we have summarized the recent progress of nanozymes in this highly active field. The antibacterial mechanisms of nanozymes and the roles of their sizes, morphologies, compositions, surface modifications and microenvironment on their overall performance have been discussed. Moreover, the current challenges and prospects in this research area have been discussed. We believe that nanozymes with unique features and functions can provide a wealth of opportunities via their clinical and industrial applications.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31482920     DOI: 10.1039/c9nr05054j

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  2 in total

Review 1.  Recent Trends in Composite Nanozymes and Their Pro-Oxidative Role in Therapeutics.

Authors:  Shilpa Maddheshiya; Seema Nara
Journal:  Front Bioeng Biotechnol       Date:  2022-05-30

2.  A WS2-gold nanoparticle heterostructure-based novel SERS platform for the rapid identification of antibiotic-resistant pathogens.

Authors:  Avijit Pramanik; Dalephine Davis; Shamily Patibandla; Salma Begum; Priyadarshini Ray; Kaelin Gates; Ye Gao; Paresh Chandra Ray
Journal:  Nanoscale Adv       Date:  2020-03-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.